Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...

Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...

In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...

While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

If you're in a relationship that faces struggles with weight and are considering GLP-1 medications like Ozempic, consider ...

Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel fuller ...

More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

The push to develop the first oral GLP-1 receptor drug for obesity is heating up, as four phase 3 drugs race to become the first approved oral treatment for obesity, Global Data reported Dec. 2. Here ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Similarly, zinc may contribute to GI issues like diarrhea or cramping. Many immune-supporting supplements combine vitamin C ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.